Literature DB >> 16819680

Lipid oxidation may reduce the quality of a fresh-frozen bone allograft. Is the approved storage temperature too high?

Minna Laitinen1, Riitta Kivikari, Martti Hirn.   

Abstract

BACKGROUND: International standards indicate that bone allografts for human use should be stored in a -40 degrees C or colder environment and the storage time should be up to 5 years. Bone allografts contain lipids which oxidate and become toxic with time.
MATERIAL AND METHODS: We determined lipid oxidation in femoral head bone allografts by headspace gas chromatography at different storage temperatures and storage times.
RESULTS: We found that lipid oxidation in fresh-frozen bone allograft was influenced by storage temperature and storage time. Lipid oxidation was significantly more rapid at -30 degrees C than at -70 degrees C. Even at -70 degrees C, however, some oxidation occurred but it was quite minimal after 3 years.
INTERPRETATION: Because of the negative effects of lipid oxidation, we recommend a storage temperature of -70 degrees C or lower for bone allografts.

Entities:  

Mesh:

Year:  2006        PMID: 16819680     DOI: 10.1080/17453670610046343

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  3 in total

1.  The impact of prolonged frozen storage on the preparation quality of bird skins and skeletons in zoological collections.

Authors:  Jessica Martínez-Vargas; Laura Roqué; Irene Del Canto; José Carrillo-Ortiz; Carles Orta; Javier Quesada
Journal:  Naturwissenschaften       Date:  2021-04-20

2.  Histological study of fresh versus frozen semitendinous muscle tendon allografts.

Authors:  Alexandre Carneiro Bitar; Luiz Augusto Ubirajara Santos; Alberto Tesconi Croci; João Alberto Ramos Maradei Pereira; Edgard N França Bisneto; Arlete Mazzini Miranda Giovani; Claudia Regina G C M Oliveira
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

3.  Bone grafting options for lumbar spine surgery: a review examining clinical efficacy and complications.

Authors:  Kenneth Vaz; Kushagra Verma; Themistocles Protopsaltis; Frank Schwab; Baron Lonner; Thomas Errico
Journal:  SAS J       Date:  2010-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.